Research
Biosimilars &
in vivo Antibodies
FEATURED PRODUCT CATEGORIES
ANTI-MOUSE ANTIBODIES
ANTI-HUMAN ANTIBODIES
Making cancer research faster and more cost effective.
Delivering research biosimilars at a faster rate to allow you to iterate your experiments quicker.
NEW PRODUCTS
View MoreAt the coalface of I-O research - biosimilars, bispecifics, ADCs, in vivo antibodies and isotype controls.
CITATIONS
Latest Publications Featuring ichorbio Products
Supporting you in producing the next great oncology breakthrough.
OUR BLOG
-
Posted: October 14, 2024Categories: ichorbio Citations (Resources)
Persistent Microglial Activation: A Double-Edged Sword in Latent Cytomegalovirus Infection
Cytomegalovirus (CMV) infection remains a significant health concern, particularly for newborns and immunocompromised individuals. A recent study by Brizić et al. sheds new light on the long-term consequences of CMV infection in the brain, revealing a complex interplay between...
-
Posted: October 14, 2024Categories: ichorbio Citations (Resources)
Riluzole Enhances Anti-PD-1 Efficacy in Colorectal Cancer by Activating cGAS/STING Signaling
Introduction
Colorectal cancer (CRC) remains a significant health challenge, ranking as the third most common cancer and the second leading cause of cancer-related deaths in the United States...
-
Posted: October 09, 2024Categories: Antibodies in Clinic / Clinical Trials
A Comprehensive Overview of Antibody Engineering Mutations
Antibody engineering has revolutionized the development of therapeutic antibodies by introducing mutations that modulate various aspects of antibody function. This overview provides a concise summary of key mutation strategies in antibody engineering, including their benefits and challenges.
...